TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training June 20, 1986
TCL Archive In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership July 10, 1992
TCL Archive In Brief: Grants Compromise Still In Doubt As Natcher, Conte Hold Out for 6,500; House Marks Up Bill July 12, 1985
TCL Archive White House FY 1979 Budget Probably Will give NCI $900 Million; NCAB Objects To ’78 Allocations November 25, 1977
